EP2098233A1 — Skin adhesive preparation comprising stabilized donepezil
Assigned to Nitto Denko Corp · Expires 2009-09-09 · 17y expired
What this patent protects
[Object] A donepezil-containing adhesive preparation is provided whereby formation of donepezil-related substances in a pressure-sensitive adhesive layer is inhibited. [Solution] A stabilizer containing one or more species selected from the group consisting of ascorbic acid…
USPTO Abstract
[Object] A donepezil-containing adhesive preparation is provided whereby formation of donepezil-related substances in a pressure-sensitive adhesive layer is inhibited. [Solution] A stabilizer containing one or more species selected from the group consisting of ascorbic acid, a metal salt or an ester thereof, isoascorbic acid or a metal salt thereof, ethylenediamine tetraacetic acid or a metal salt thereof, cysteine, acetylcysteine, 2-mercaptobenzimidazole, 3(2)-t-butyl-4-hydroxyanisole, 2,6-di-t-butyl-4-methylphenol, tetrakis[3-(3',5'-di-t-butyl-4'-hydroxyphenyl)propionic acid]pentaerythritol, 3-mercapto-1,2-propanediol, tocopherol acetate, rutin, quercetin, hydroquinone, a metal salt of hydroxymethanesulfinic acid, a metal metabisulfite salt, a metal sulfite salt and a metal thiosulfate salt, is blended in a donepezil-containing pressure-sensitive adhesive layer provided on at least one side of a support.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.